Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical cord mesenchymal stem cell transplantation via femoral artery for spinal cord injury
ChiCTR-ONC-12002005Phase 2Completed
- Sponsor
- The Third Medical Center of the Chinese People's Liberation Army General Hospital
- Start
- Apr 2012
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of human umbilical cord mesenchymal stem cells in spinal cord injury (SCI), sponsored by The Third Medical Center of the Chinese People's Liberation Army General Hospital. Primary endpoints: Urodynamic test and Electrophysiology: motor and somatosensory evoked potentials. Started Apr 2012; status: completed.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
spinal cord injury (SCI)
Beyond the preview
Go deeper on ChiCTR-ONC-12002005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONC-12002005.